Summer 2026

Wealth Management Intern

Posted on 5/7/2026

UBS

UBS

10,001+ employees

Investment bank and wealth, asset manager

No salary listed

Baltimore, MD, USA

Hybrid

2-3 days per week on-site at Baltimore office.

Category
Finance & Banking (1)
Required Skills
Market Research
Financial analysis
Excel/Numbers/Sheets
Requirements
  • enrolled in a two- or four-year college or university
  • a balanced resume which includes solid academic performance and campus involvement
  • a genuine interest in exploring the field of Wealth Management
  • analyze a problem, produce ideas, and come to a decision
  • take ownership, be organized, and can execute
  • be detail-oriented and can stick with a task and follow instructions
  • communicate well and work within a team
  • show good judgement
Responsibilities
  • work on projects that have a real impact on clients and gain product knowledge
  • support our team of Wealth Management advisors and wealth strategy associates
  • compile market and investment research
  • leverage Microsoft Excel skills to assist with portfolio analysis
  • prepare client meeting materials and generate performance reports
  • assist with the responsibilities of running an entrepreneurial business model
  • attend presentations by WMA leaders to help you understand our industry, culture and strategy

UBS Group AG is a Swiss multinational financial services firm with four divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, and the Investment Bank. It serves private, corporate, institutional, and retail clients worldwide, offering wealth planning for high-net-worth individuals, Swiss banking services, a broad range of investment products, and advisory, underwriting, and trading in equities, fixed income, rates, and FX. It earns fees from wealth and asset management, interest income from lending, and trading income from investment banking. Its aim is to help clients manage and grow wealth while delivering diversified, revenue-generating financial services across regions and asset classes.

Company Size

10,001+

Company Stage

IPO

Headquarters

Zurich, Switzerland

Founded

1998

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 profit surges 80% to $3B on record $3.2B markets revenue from volatility.
  • US national banking license enables Americas acquisitions after $37.4B net new assets.
  • $1.12B MicroStrategy stake and $1.5M XRP ETFs tap accelerating crypto adoption.

What critics are saying

  • Swiss rules impose $20B capital buffer, halting US acquisitions and $3B buybacks.
  • Morgan Stanley, JPMorgan poach advisors, eroding South Florida wealth market share.
  • Bitcoin 50% crash inflicts 20-30% losses on $1.12B MicroStrategy stake in 3-6 months.

What makes UBS unique

  • UBS leads as largest global wealth manager with Swiss universal banking dominance.
  • Investment Bank delivers advisory, underwriting, and trading across equities, fixed income.
  • Personal & Corporate Banking serves Swiss retail, corporates, institutions exclusively.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at UBS who can refer or advise you

Benefits

Flexible Work Hours

Remote Work Options

Professional Development Budget

Company News

CryptoRobotics
May 8th, 2026
UBS invests $1.5M in XRP through ETFs, marking shift in institutional crypto adoption

UBS has invested $1.5 million in XRP through the Volatility Shares XRP ETF and Grayscale XRP Trust, according to a recent SEC filing. The Swiss bank holds 197,369 shares in the ETF and 317 shares in the trust. The investment represents a strategic approach to cryptocurrency exposure through regulated products rather than direct holdings, reflecting broader institutional trends favouring compliance and risk management. This comes as XRP ETFs experience significant inflows whilst Bitcoin and Ethereum face notable outflows. UBS's move signals growing institutional confidence in XRP and regulated crypto products. The development may encourage retail investors to follow suit, particularly in emerging markets, as traditional financial institutions increasingly participate in the cryptocurrency sector through compliant investment vehicles.

Investors in Healthcare
Apr 13th, 2026
DentaCore secures $168M financing to fuel Swiss dental platform expansion

DentaCore Group, a Swiss dental platform, has secured CHF150 million (US$190 million) in financing to repay existing debt and fund future acquisitions. The package includes a term loan, revolving credit facility and incremental facility. Founded in 2021, DentaCore specialises in acquiring and consolidating dental practices, clinics and laboratories. The company has rapidly scaled to over 60 dental practices and laboratories through more than 40 acquisitions. UBS served as sole mandated lead arranger, bookrunner and agent for a CHF120 million term loan and revolving credit facility. Houlihan Lokey acted as exclusive financing adviser, whilst MLL Legal provided legal counsel. In 2025, Capital Transmission, a Swiss investment company within the BCGE Group, invested in DentaCore.

Sina Finance
Apr 13th, 2026
UBS raises stake in Luye Pharma with $5.1M purchase at $0.37 per share

UBS has increased its stake in Luye Pharma (02186) by 13.95 million shares at approximately HK$2.85 per share, for a total consideration of around HK$39.84 million, according to Hong Kong Stock Exchange filings dated 2 April. Following the transaction, UBS now holds approximately 403 million shares, representing a 10.09% stake in the company. The filing notes that 218.5 million of the reported positions relate to a securities lending agreement executed alongside a convertible bond issuance disclosed on 28 June 2023.

Legal Community
Apr 13th, 2026
Advestra with UBS on CHF 100 m credit to Gasverbund Mittelland - Legalcommunity.ch

Advestra advised UBS Switzerland as coordinator, agent, fronting bank and lender, alongside the other syndicate banks as lenders, on the CHF 100 million credit facility provided to Gasverbund Mittelland, a procurement and grid company of natural and biogas active across the Plateau and Northwestern regions in Switzerland.

Structured Retail Products
Apr 13th, 2026
MerQube secures Series C funding from 7RIDGE and Deutsche Börse to scale derivatives-linked ETF platform

MerQube, a US-based index provider specialising in rules-based and derivatives-enabled strategies, has closed a Series C funding round led by 7RIDGE and Deutsche Börse Group. Existing investors including Allianz Life Ventures, Citi, Intel Capital, J.P. Morgan, Laurion Capital Management and UBS also participated, though the funding amount was not disclosed. The company plans to use the investment to scale its technology platform and expand in derivatives-linked ETF and structured product markets. MerQube focuses on providing customised index solutions and data-driven strategies for institutional clients.